FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954927350> ?p ?o ?g. }

• W2954927350 endingPage "1863" @default.
• W2954927350 startingPage "1863" @default.
• W2954927350 abstract "Abstract Traditional Chinese Medicine (TCM) is a holistic system that has been widely used in the treatment of allergy, and several specific herbal formulations have been used as treatment agents. One such compound, berberine, is a plant alkaloid isolated from Phellodendri chinensis. Berberine has been widely used in both Chinese and Ayurvedic medicine and has antimicrobial and antiprotozoal properties. Additional pharmacologic actions reported include anticancer activity as well as anti-inflammatory effects, specifically suppression of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha. Berberine has been shown to inhibit IgE production in myeloma cell line U266 without cytotoxicity. In U266 berberine inhibits nuclear translocation of NFκB by dampening phosphorylated IκB expression, subsequently decreasing activation of the ϵ-germline transcript promoter and suppressing IgE synthesis. Since this pathway plays a crucial role in many aspects of tumorigenesis, we hypothesized that this could have anticancer activity in solid tumors, specifically melanoma and anaplastic thyroid cancer (ATC). Melanoma and thyroid cancer are diagnosed with a high incidence, increasing over the last few decades. Newer therapies being evaluated in melanoma and thyroid cancer include checkpoint inhibitors. These therapeutic modalities, like others, have off target effects and high relapse rates due to acquired resistance. To identify safer alternative therapeutic strategies we characterized berberine for its anticancer properties through an in vitro proliferation assay with XTT on three melanoma cell lines (SKMEL28, SKMEL37, and SKMEL103), four ATC cell lines (T238, SW1736, HTh74, and 8505C), and three papillary thyroid cancer cell lines (TPC1, BCPAP, and K1). These cell lines were treated with 2μM berberine for 24 hrs. Berberine inhibited cellular proliferation in a dose and time dependent manner in all of these tumor types. ATC cell lines showed more sensitivity towards the drug compared to the other morphotypes. This is specifically significant since therapeutic options for ATC are extremely limited. Both ATC and melanoma have a high nuclear NFκB level, potentially contributing towards their aggressive phenotype. Cells were treated with 2μM berberine and expression of cyclinD1, CDK2, Bcl2, TRAF1, TRAF2 and IAP were evaluated by western blot. Berberine showed a differential regulation of these molecules in melanoma and thyroid cancer. This study opens up a new avenue for the adjuvant treatment of these malignancies using naturally occurring compounds. Citation Format: Tara Jarboe, Michelle Carnazza, Sanjukta Chakraborty, Nan Yang, Kamal Srivastava, Jan Geliebter, Raj K. Tiwari, Xiu-Min Li. Identification of anticancer agent from antiallergic treatment regimens of traditional Chinese medicine [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1863." @default.
• W2954927350 created "2019-07-12" @default.
• W2954927350 creator A5006905292 @default.
• W2954927350 creator A5026369750 @default.
• W2954927350 creator A5036740014 @default.
• W2954927350 creator A5037029599 @default.
• W2954927350 creator A5062643097 @default.
• W2954927350 creator A5064167770 @default.
• W2954927350 creator A5071319432 @default.
• W2954927350 creator A5088736113 @default.
• W2954927350 date "2019-07-01" @default.
• W2954927350 modified "2023-10-02" @default.
• W2954927350 title "Abstract 1863: Identification of anticancer agent from antiallergic treatment regimens of traditional Chinese medicine" @default.
• W2954927350 doi "https://doi.org/10.1158/1538-7445.am2019-1863" @default.
• W2954927350 hasPublicationYear "2019" @default.
• W2954927350 type Work @default.
• W2954927350 sameAs 2954927350 @default.
• W2954927350 citedByCount "0" @default.
• W2954927350 crossrefType "journal-article" @default.
• W2954927350 hasAuthorship W2954927350A5006905292 @default.
• W2954927350 hasAuthorship W2954927350A5026369750 @default.
• W2954927350 hasAuthorship W2954927350A5036740014 @default.
• W2954927350 hasAuthorship W2954927350A5037029599 @default.
• W2954927350 hasAuthorship W2954927350A5062643097 @default.
• W2954927350 hasAuthorship W2954927350A5064167770 @default.
• W2954927350 hasAuthorship W2954927350A5071319432 @default.
• W2954927350 hasAuthorship W2954927350A5088736113 @default.
• W2954927350 hasConcept C121608353 @default.
• W2954927350 hasConcept C126322002 @default.
• W2954927350 hasConcept C164027704 @default.
• W2954927350 hasConcept C203014093 @default.
• W2954927350 hasConcept C2776914184 @default.
• W2954927350 hasConcept C2777658100 @default.
• W2954927350 hasConcept C2779761222 @default.
• W2954927350 hasConcept C2780116568 @default.
• W2954927350 hasConcept C2780256643 @default.
• W2954927350 hasConcept C2781461381 @default.
• W2954927350 hasConcept C502942594 @default.
• W2954927350 hasConcept C556039675 @default.
• W2954927350 hasConcept C71924100 @default.
• W2954927350 hasConcept C98274493 @default.
• W2954927350 hasConceptScore W2954927350C121608353 @default.
• W2954927350 hasConceptScore W2954927350C126322002 @default.
• W2954927350 hasConceptScore W2954927350C164027704 @default.
• W2954927350 hasConceptScore W2954927350C203014093 @default.
• W2954927350 hasConceptScore W2954927350C2776914184 @default.
• W2954927350 hasConceptScore W2954927350C2777658100 @default.
• W2954927350 hasConceptScore W2954927350C2779761222 @default.
• W2954927350 hasConceptScore W2954927350C2780116568 @default.
• W2954927350 hasConceptScore W2954927350C2780256643 @default.
• W2954927350 hasConceptScore W2954927350C2781461381 @default.
• W2954927350 hasConceptScore W2954927350C502942594 @default.
• W2954927350 hasConceptScore W2954927350C556039675 @default.
• W2954927350 hasConceptScore W2954927350C71924100 @default.
• W2954927350 hasConceptScore W2954927350C98274493 @default.
• W2954927350 hasIssue "13_Supplement" @default.
• W2954927350 hasLocation W29549273501 @default.
• W2954927350 hasOpenAccess W2954927350 @default.
• W2954927350 hasPrimaryLocation W29549273501 @default.
• W2954927350 hasRelatedWork W2028411003 @default.
• W2954927350 hasRelatedWork W2103133857 @default.
• W2954927350 hasRelatedWork W2163852686 @default.
• W2954927350 hasRelatedWork W2179395367 @default.
• W2954927350 hasRelatedWork W2913421951 @default.
• W2954927350 hasRelatedWork W4205810287 @default.
• W2954927350 hasRelatedWork W4242084678 @default.
• W2954927350 hasRelatedWork W4282973338 @default.
• W2954927350 hasRelatedWork W760438382 @default.
• W2954927350 hasRelatedWork W2186045506 @default.
• W2954927350 hasVolume "79" @default.
• W2954927350 isParatext "false" @default.
• W2954927350 isRetracted "false" @default.
• W2954927350 magId "2954927350" @default.
• W2954927350 workType "article" @default.